Sunday, October 26, 2025
Distribution: (800) 510 0384
Washington DC
New York
Toronto
Press ID  
  • Login
The Hudson Weekly
  • Financial
  • Blockchain
  • Technology
  • Entertainment
  • Lifestyle
  • Arts
  • Health
  • Sports
  • Cybersecurity
No Result
View All Result
  • Financial
  • Blockchain
  • Technology
  • Entertainment
  • Lifestyle
  • Arts
  • Health
  • Sports
  • Cybersecurity
No Result
View All Result
The Hudson Weekly
No Result
View All Result

FDA Approves Treatment for Chronic Kidney Disease

Approval is First to Cover Many Causes of Disease

Craig Richer by Craig Richer
May 3, 2021
in Health
A A
Share on FacebookShare on Twitter

U.S. Food and Drug Administration approved Farxiga (dapagliflozin) oral tablets to reduce the risk of kidney function decline, kidney failure, cardiovascular death and hospitalization for heart failure in adults with chronic kidney disease who are at risk of disease progression.

“Chronic kidney disease is an important public health issue, and there is a significant unmet need for therapies that slow disease progression and improve outcomes,” said Aliza Thompson, M.D., M.S., deputy director of the Division of Cardiology and Nephrology in the FDA’s Center for Drug Evaluation and Research. “Today’s approval of Farxiga for the treatment of chronic kidney disease is an important step forward in helping people living with kidney disease.”

HudsonNewsroom

How to Use Feeding Bra Properly: What Every Mom Should Know

Every Child in America Doesn’t Need Therapy

Overcoming Imposter Syndrome in Medicine: Dr. Michael Everest’s Perspective

Chronic kidney disease occurs when the kidneys are damaged and cannot filter blood normally. Due to this defective filtering, patients can have complications related to fluid, electrolytes (minerals required for many bodily processes), and waste build-up in the body. Chronic kidney disease sometimes can progress to kidney failure. Patients also are at high risk of cardiovascular disease, including heart disease and stroke.

The efficacy of Farxiga to improve kidney outcomes and reduce cardiovascular death in patients with chronic kidney disease was evaluated in a multicenter, double-blind study. In this study, 4,304 patients were randomly assigned to receive either Farxiga or a placebo. The study compared the two groups for the number of patients whose disease progressed to a composite (or combined) endpoint that included at least a 50% reduction in kidney function, progression to kidney failure, or cardiovascular or kidney death. Results showed that 197 of the 2,152 patients who received Farxiga had at least one of the composite endpoint events compared to 312 of the 2,152 patients who received a placebo. The study also compared the two groups for the number of patients who were hospitalized for heart failure or died from cardiovascular disease. A total of 100 patients who received Farxiga were hospitalized or died compared to 138 patients who received a placebo.

Farxiga was not studied, nor is expected to be effective, in treating chronic kidney disease among patients with autosomal dominant or recessive polycystic (characterized by multiple cysts) kidney disease or among patients who require or have recently used immunosuppressive therapy to treat kidney disease.

Patients should not use Farxiga if they have a history of serious hypersensitivity reactions to the medication or if they are on dialysis treatment. Serious, life-threatening cases of Fournier’s Gangrene have occurred in patients with diabetes taking Farxiga. Patients should consider a lower dose of insulin or insulin secretagogue to reduce the risk of hypoglycemia (low blood sugar) if they are also taking Farxiga. Farxiga can cause dehydration, serious urinary tract infections, genital yeast infections, and metabolic acidosis or ketoacidosis (acid build-up in the blood). Patients should be assessed for their volume status and kidney function before starting Farxiga.

Farxiga was originally approved in 2014 to improve glycemic control in adults with type 2 diabetes in addition to diet and exercise.

Farxiga received Fast Track, Breakthrough Therapy, and Priority Review designations for the indication being approved today. Fast track is designed to facilitate the development and expedite the review of drugs to treat serious conditions and fill an unmet medical need. Breakthrough therapy designation is designed to expedite the development and review of drugs that are intended to treat a serious condition and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over available therapy on a clinically significant endpoint(s). Priority review directs overall attention and resources to the evaluation of applications for drugs that, if approved, would be significant improvements in the safety or effectiveness of the treatment, diagnosis or prevention of serious conditions when compared to standard applications.

The FDA granted the approval of Farxiga to AstraZeneca.

Craig Richer

Craig Richer

Newsroom Editor

More from HW Newsdesk

How to Use Feeding Bra Properly: What Every Mom Should Know
Health

How to Use Feeding Bra Properly: What Every Mom Should Know

October 23, 2025
Every Child in America Doesn’t Need Therapy
Health

Every Child in America Doesn’t Need Therapy

October 20, 2025
Overcoming Imposter Syndrome in Medicine: Dr. Michael Everest’s Perspective
Health

Overcoming Imposter Syndrome in Medicine: Dr. Michael Everest’s Perspective

October 16, 2025

HW Newsroom

doTERRA's Global Convention Demonstrates Multi-Tiered Empowerment Model
Arts

doTERRA’s Global Convention Demonstrates Multi-Tiered Empowerment Model

by Nicole Choquette
October 22, 2025

Salt Lake City hosted doTERRA's 2025 Global Convention from Sept. 18-20, drawing attendance exceeding 10,000 individuals through combined in-person and...

How Does External Storage Enhance Your Investment Strategy?

How Does External Storage Enhance Your Investment Strategy?

October 21, 2025
Neutec Group Partners With Bioz to Enhance Scientific Product Validation

Neutec Group Partners With Bioz to Enhance Scientific Product Validation

October 21, 2025
California's Lancaster Introduces Hydrogen-Powered Backup Traffic Signals to Boost Public Safety

California’s Lancaster Introduces Hydrogen-Powered Backup Traffic Signals to Boost Public Safety

October 21, 2025
A Complete Review of Spin Samurai Casino – the Perfect Choice for Australian Players

A Complete Review of Spin Samurai Casino – the Perfect Choice for Australian Players

October 21, 2025
Every Child in America Doesn’t Need Therapy

Every Child in America Doesn’t Need Therapy

October 20, 2025
Signs Your Dog Needs More Exercise Than You Think in the Windy City

Signs Your Dog Needs More Exercise Than You Think in the Windy City

October 20, 2025
The Role of Artificial Intelligence in Modern Casino Operations

History of Lightning Link Casino Slots

October 20, 2025
4 Easy Ways to Keep Your Pet Comfortable Year-Round

4 Easy Ways to Keep Your Pet Comfortable Year-Round

October 19, 2025
Tom Vukota Delivers Returns Through Secular Trend Execution in Colorado Workforce Housing

Tom Vukota Delivers Returns Through Secular Trend Execution in Colorado Workforce Housing

October 19, 2025
Overcoming Imposter Syndrome in Medicine: Dr. Michael Everest’s Perspective

Overcoming Imposter Syndrome in Medicine: Dr. Michael Everest’s Perspective

October 16, 2025
Are You Under 40 and Want to Invest? Here’s Where to Begin

Are You Under 40 and Want to Invest? Here’s Where to Begin

October 16, 2025
No Result
View All Result

Headlines

A Beginner’s Guide to Starting a DTF Printing Business

How to Use Feeding Bra Properly: What Every Mom Should Know

Discover the World of Prop Firm Trading

doTERRA’s Global Convention Demonstrates Multi-Tiered Empowerment Model

How Does External Storage Enhance Your Investment Strategy?

Neutec Group Partners With Bioz to Enhance Scientific Product Validation

Trending

How Online Casino Platforms Are Embracing Safer-Gaming Tools and Regulation
Cybersecurity

How Online Casino Platforms Are Embracing Safer-Gaming Tools and Regulation

by Craig Richer
October 24, 2025

Online gaming has developed at an immensely fast pace over the last ten years, from a niche...

Ryan The Son Turns Recovery Into a Sport on Recovering Athlete

Ryan The Son Turns Recovery Into a Sport on Recovering Athlete

October 24, 2025
A Beginner's Guide to Starting a DTF Printing Business

A Beginner’s Guide to Starting a DTF Printing Business

October 23, 2025
How to Use Feeding Bra Properly: What Every Mom Should Know

How to Use Feeding Bra Properly: What Every Mom Should Know

October 23, 2025
Discover the World of Prop Firm Trading

Discover the World of Prop Firm Trading

October 22, 2025
  • Why Adaptability is the Ultimate Business Advantage: Insights From Dustin Pillonato

https://madisongraph.com/why-adaptability-is-the-ultimate-business-advantage-insights-from-dustin-pillonato/

#nyc #losangeles #chicago #houston #phoenix #philadelphia #sandiego #dallas #sanfrancisco #seattle #denver #washingtondc #boston #detroit #vancouver #toronto #publicrelations #marketingagency #earnedmedia #editorial #marketing #guestpost #guestposting #sponsored #sponsoredpost
  • Bridging the Gap: Greg Kutzin on How Business Analysts Can Drive Change in Diverse Industries

https://madisongraph.com/bridging-the-gap-greg-kutzin-on-how-business-analysts-can-drive-change-in-diverse-industries/

#GuestPostService #SponsoredPost #DigitalPR #SEOAgency #ContentMarketing #MediaCoverage #BacklinkService #AuthorityBranding #FounderLife #MarketingAgency #EarnedMedia #PressReleaseDistribution #LinkBuildingService #StartupMarketing #NYC
  • Waad Sartawi: The Future of Drama Writing

https://marketsherald.com/waad-sartawi-the-future-of-drama-writing/

#nyc #losangeles #chicago #houston #phoenix #philadelphia #sandiego #dallas #sanfrancisco #seattle #denver #washingtondc #boston #detroit #vancouver #toronto #publicrelations #marketingagency #earnedmedia #editorial #marketing #guestpost #guestposting #sponsored #sponsoredpost #writings #book
  • Nick Warner, Lobbyist Powerhouse – Turned – Business Coach, Shares his Experience and Insights on Leadership & Strategy With Victor Migalchan on California LIVE Podcast

https://fairmontpost.com/nick-warner-lobbyist-powerhouse-turned-business-coach-shares-his-experience-and-insights-on-leadership-strategy-with-victor-migalchan-on-california-live-podcast/

#nyc #losangeles #chicago #houston #phoenix #philadelphia #sandiego #dallas #sanfrancisco #seattle #denver #washingtondc #boston #detroit #vancouver #toronto #publicrelations #marketingagency #earnedmedia #editorial #marketing #guestpost #guestposting #sponsored #sponsoredpost #california #podcasting
  • Weber Financial Group Redefines Client-Centric Service in Newport Beach

https://belmontstar.com/weber-financial-group-redefines-client-centric-service-in-newport-beach/

#nyc #losangeles #chicago #houston #phoenix #philadelphia #sandiego #dallas #sanfrancisco #seattle #denver #washingtondc #boston #detroit #vancouver #toronto #publicrelations #marketingagency #earnedmedia #editorial #marketing #guestpost #guestposting #sponsored #sponsoredpost #lawyerlife
  • New Jersey Students Turn to Trade Careers as College Costs Rise: A Path to Debt-Free Success

https://fairmontpost.com/new-jersey-students-turn-to-trade-careers-as-college-costs-rise-a-path-to-debt-free-success/

#nyc #losangeles #chicago #houston #phoenix #philadelphia #sandiego #dallas #sanfrancisco #seattle #denver #washingtondc #boston #detroit #vancouver #toronto #publicrelations #marketingagency #earnedmedia #editorial #marketing #guestpost #guestposting #sponsored #sponsoredpost #newjersery
  • Sprouting Into the Spotlight: Doug Evans Makes Waves on Shark Tank

https://marketsherald.com/sprouting-into-the-spotlight-doug-evans-makes-waves-on-shark-tank/

#nyc #losangeles #chicago #houston #phoenix #philadelphia #sandiego #dallas #sanfrancisco #seattle #denver #washingtondc #boston #detroit #vancouver #toronto #publicrelations #marketingagency #earnedmedia #editorial #marketing #guestpost #guestposting #sponsored #sponsoredpost #healthyfoodie
  • JRM Construction Management Plays Key Role in Building JPMorgan Chase’s New Global Headquarters

https://marketsherald.com/jrm-construction-management-plays-key-role-in-building-jpmorgan-chases-new-global-headquarters/

#GuestPostService #SponsoredPost #DigitalPR #SEOAgency #ContentMarketing #MediaCoverage #BacklinkService #AuthorityBranding #FounderLife #MarketingAgency #EarnedMedia #PressReleaseDistribution #LinkBuildingService #StartupMarketing #NYC

© 2025 The Hudson Weekly. Published by The Ritz Herald. Editions: Markets Herald • Lincoln Citizen • Madison Graph • Belmont Star • Fairmont Post

Address: 1177 6th Avenue, 5th Floor, New York, NY 10036. Removals: pr@hudsonweekly.com. Phone: (718) 313-5252. M-F: 9AM-5PM. Privacy Policy

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

No Result
View All Result
  • Financial
  • Blockchain
  • Technology
  • Entertainment
  • Lifestyle
  • Arts
  • Health
  • Sports
  • Cybersecurity

© 2025. The Hudson Weekly